Target trades at historically low multiples, with downside risks likely priced in, and offers a compelling 5.12% dividend.

BALTIMORE — Integrative approaches to addressing both mental and physical health may be the next step in successful treatment for individuals with epilepsy, according to a presenter at the American ...